ChIP-seq of PPARGC1A in oesophageal adenocarcinoma OE19 cells treated with lapatinib

ABSTRACT: ChIP-seq for PPARGC1A was performed in OE19 cells to identify genomic binding sites. Cells were treated with 500 nM lapatinib for 48 hours.

INSTRUMENT(S): Illumina HiSeq 4000

ORGANISM(S): Homo sapiens

SUBMITTER: Sam Ogden 

PROVIDER: E-MTAB-11300 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress